↓ SCROLL TO SEE MORE ↑

What are you looking for?

News

Two medications for people at risk of severe COVID have been approved by an EU regulator

Two medications for people at risk of severe COVID have been approved by an EU regulator

The European Medicines Agency (EMA) approved the marketing authorisation of Ronapreve and Regkirona, two anti-COVID medicines, on Thursday.

Ronapreve and Regkirona are both based on monoclonal antibody medicines using proteins designed to recognize and attach to the spike protein of the COVID-19 virus.

The EU regulator recommends Ronapreve for preventing COVID-19 as well as treating coronavirus patients older than 12 years who do not require supplemental oxygen and who are at increased risk of their disease becoming severe.

In the case of Regkirona, the EMA recommends treatment for adults who do not require supplemental oxygen and are also at increased risk of becoming severely ill.

Following the recommendation of the EMA, the European Commission will officially authorize the medicines to be marketed in the EU.

Ronapreve was developed by US-Swiss pharma companies Regeneron-Roche, while Regkirona is the invention of South Korea’s Celltrion.

News

The first monkeypox case in Türkiye was confirmed on Thursday. “Monkeypox was detected in one of our patients. The patient is 37 years old,...

News

Prime Minister Hun Sen’s Friday warned to jail those responsible for spreading fake news. “Please do not take the COVID-19 issue as a joke,...

News

A group of Turkish scientists applied to health authorities for human trials of an innovative nasal spray developed against COVID-19 and influenza. Animal trials...

News

Cities and coastal resorts in Turkey are gearing up for an influx of travelers now that Turkey has extended the upcoming religious holiday, in...